Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy

Circulation. 1998 Oct 27;98(17):1750-5. doi: 10.1161/01.cir.98.17.1750.

Abstract

Background: Left ventricular outflow tract (LVOT) obstruction is frequently responsible for symptoms in hypertrophic obstructive cardiomyopathy (HOCM). Medical therapy is often not sufficient to control these symptoms, and surgical myotomy-myomectomy is required.

Methods and results: We enrolled 33 symptomatic patients with HOCM and obstruction (>/=40 mm Hg gradient at rest or >/=60 mm Hg dobutamine-provoked). By contrast echocardiography, the bulging septum was localized and infarcted by injection of 2 to 5 mL of absolute ethanol into the septal artery(ies) supplying the hypertrophied area. Baseline echocardiograms with Doppler, myocardial perfusion tomograms, and treadmill exercise or pharmacological testing were compared with those at 6 weeks and 6 months. The mean rise in creatine kinase was 1964+/-796 U. All patients experienced symptomatic relief; NYHA class decreased from 3. 0+/-0.5 to 0.9+/-0.6 (P<0.001). Exercise time increased from 286+/-193 to 421+/-181 seconds (P=0.03). The resting and dobutamine-provoked gradient decreased from 49+/-33 and 96+/-34 mm Hg to 9+/-19 (P<0.001) and 24+/-31 mm Hg (P<0.001), respectively. Echocardiograms repeated at 6 weeks after the procedure showed a 28% reduction in septal thickness and 17% reduction in left ventricular mass. Myocardial perfusion imaging showed a "septal amputation pattern," with scarring in the upper and middle septal areas. Complete heart block developed in 11 patients, who then required permanent pacemaker implantation.

Conclusions: Echocardiography-guided ethanol septal reduction in patients with HOCM is a safe, minimally invasive procedure that provides symptomatic relief with improved hemodynamic and left ventricular parameters.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cardiomyopathy, Restrictive / drug therapy*
  • Creatine Kinase / blood
  • Echocardiography
  • Electrocardiography
  • Ethanol / therapeutic use*
  • Female
  • Heart Septum / drug effects*
  • Hemodynamics / drug effects
  • Humans
  • Male
  • Middle Aged
  • Necrosis
  • Tomography, Emission-Computed, Single-Photon
  • Ventricular Outflow Obstruction / complications
  • Ventricular Outflow Obstruction / diagnostic imaging
  • Ventricular Outflow Obstruction / drug therapy*

Substances

  • Ethanol
  • Creatine Kinase